Skip to main content

Closed

ZTS: Zoetis Inc. Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+8.3% / yr

Operating margin37.6%

ROIC21.8%

Financially safe

Strong

Debt / equity2.86×

Interest coverage14.8×

Current ratio3.15×

Valuation

Unrated

P/E ratio12.8×

Dividend yield2.7%

Zoetis Inc.

ZTSNew York Stock Exchange·USD·Closed

Zoetis Inc.

ZTSNew York Stock Exchange·USD·Closed

$77.29

+1.66%

$77.29

+$1.26 (1.66%)

52W Range

7thpctl

Volume

0.66×avg

Mkt Cap

32.40BUSD

P/E

12.8TTM

Div Yield

2.70%ann

52W Range

7thpctl

Volume

0.66×avg

Market Cap

32.40BUSD

P/E Ratio

12.8TTM

Div Yield

2.70%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings